Description
Zopimaxx 25 mg is a very high-dose formulation of zopiclone, a non-benzodiazepine hypnotic agent prescribed for the short-term management of insomnia. It is intended for individuals experiencing significant sleep disturbances, including difficulty falling asleep, frequent nighttime awakenings, or poor sleep quality.
Zopiclone works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter responsible for reducing brain excitability. By binding to GABA-A receptors, it produces sedative and relaxing effects that promote sleep onset and maintenance. Although it interacts with similar receptor sites as benzodiazepines, it has a different chemical structure and classification.
A 25 mg dose is substantially higher than the typical recommended adult dose (commonly 3.75 mg to 7.5 mg). Such a high strength may significantly increase the risk of side effects, including excessive sedation, confusion, impaired coordination, memory disturbances, and next-day drowsiness. It should only be used under strict medical supervision and when specifically prescribed.
Common side effects may include a bitter or metallic taste, dry mouth, dizziness, headache, and drowsiness. Higher doses may increase the risk of unusual sleep behaviors (such as sleepwalking), mood changes, respiratory depression, dependence, or withdrawal symptoms with prolonged use.
Zopimaxx 25 mg should not be combined with alcohol or other sedative medications due to the risk of severe sedation and breathing difficulties. Individuals with liver disease, respiratory disorders, a history of substance misuse, or mental health conditions should use this medication only under careful medical supervision.
Reviews
There are no reviews yet.